Complete mitochondrial genome of Dong Tao chicken breed (Gallus gallus domesticus) of Vietnam

The complete mitochondrial genome of Dong Tao chicken breed (Gallus gallus domesticus, Dong Tao) was obtained by PCR and sequencing. The complete mitogenome was 16,783 bp in length, with the nucleotide composition for A, T, C, G was 30.29%, 23.75%, 32.48%, and 13.48%, respectively. The mitogenome of Dong Tao chicken contained a non-coding control region (D-loop), 2 rRNA genes, 13 protein-coding genes, and 22 tRNA genes. Phylogenetic analysis revealed that breed Dong Tao chicken breed was sister-close to G. gallus breed Guangxi, and paraphyletic to G. spadiceus, S. jabouillei, and a range of Chinese indigenous, ie. breeds Rugao and Taoyuan

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Background: Late treatment failures after artemisinin-based combination therapies (ACTs) for falciparum malaria have increased in the Greater Mekong subregion in southeast Asia. Addition of amodiaquine to artemether-lumefantrine could provide an efficacious treatment for multidrug-resistant infections. Methods: We conducted an open-label, randomised trial at five hospitals or health centres in three locations (western Cambodia, eastern Cambodia, and Vietnam). Eligible participants were male and female patients aged 2-65 years with uncomplicated Plasmodium falciparum malaria. Patients were randomly allocated (1:1 in blocks of eight to 12) to either artemether-lumefantrine alone (dosed according to WHO guidelines) or artemether-lumefantrine plus amodiaquine (10 mg base per kg/day), both given orally as six doses over 3 days. All received a single dose of primaquine (0·25 mg/kg) 24 h after the start of study treatment to limit transmission of the parasite. Parasites were genotyped, identifying artemisinin resistance. The primary outcome was Kaplan-Meier 42-day PCR-corrected efficacy against recrudescence of the original parasite, assessed by intent-to-treat. Safety was a secondary outcome. This completed trial is registered at ClinicalTrials.gov (NCT03355664). Findings: Between March 18, 2018, and Jan 30, 2020, 310 patients received randomly allocated treatment; 154 received artemether-lumefantrine alone and 156 received artemether-lumefantrine plus amodiaquine. Parasites from 305 of these patients were genotyped. 42-day PCR-corrected treatment efficacy was noted in 151 (97%, 95% CI 92-99) of 156 patients with artemether-lumefantrine plus amodiaquine versus 146 (95%, 89-97) of 154 patients with artemether-lumefantrine alone; hazard ratio (HR) for recrudescence 0·6 (95% CI 0·2-1·9, p=0·38). Of the 13 recrudescences, 12 were in 174 (57%) of 305 infections with pfkelch13 mutations indicating artemisinin resistance, for which 42-day efficacy was noted in 89 (96%) of 93 infections with artemether-lumefantrine plus amodiaquine versus 73 (90%) of 81 infections with artemether-lumefantrine alone; HR for recrudescence 0·44 (95% CI 0·14-1·40, p=0·17). Artemether-lumefantrine plus amodiaquine was generally well tolerated, but the number of mild (grade 1-2) adverse events, mainly gastrointestinal, was greater in this group compared with artemether-lumefantrine alone (vomiting, 12 [8%] with artemether-lumefantrine plus amodiaquine vs three [2%] with artemether-lumefantrine alone, p=0·03; and nausea, 11 [7%] with artemether-lumefantrine plus amodiaquine vs three [2%] with artemether-lumefantrine alone, p=0·05). Early vomiting within 1 h of treatment, requiring retreatment, occurred in no patients of 154 with artemether-lumefantrine alone versus five (3%) of 156 with artemether-lumefantrine plus amodiaquine, p=0·06. Bradycardia (≤54 beats/min) of any grade was noted in 59 (38%) of 154 patients with artemether-lumefantrine alone and 95 (61%) of 156 with artemether-lumefantrine plus amodiaquine, p=0·0001. Interpretation: Artemether-lumefantrine plus amodiaquine provides an alternative to artemether-lumefantrine alone as first-line treatment for multidrug-resistant P falciparum malaria in the Greater Mekong subregion, and could prolong the therapeutic lifetime of artemether-lumefantrine in malaria-endemic populations

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

Financial analysis of company Epiag Lofida – Porcelán CZ s.r.o.

The aim of this bachelor thesis is to analyse and evaluate financial health of manufacturing company Epiag lofida -- Porcelán CZ s.r.o. in a period of years 2006 -- 2011. Thesis is devided into three parts: theoretical, practical and conclusion. In theoretical part, there is described methodology of calculations used in analysis - horizontal and vertical analysis of financial statements, indicators of profitability, liquidity, leverage, activity, bankrupt and financial standing models. The practical part consists of the application which is analyzed in the theoretical part of the thesis from different points of view. In conclusion of this thesis I evaluate results found in the practical part

Financial analysis of company Epiag Lofida \u2013 Porcelán CZ s.r.o.

Cílem této bakalářské práce je analyzovat a zhodnotit finanční zdraví výrobního podniku Epiag Lofida -- Porcelán CZ s.r.o. Práce je rozdělena do tří části-teoretická, praktická a závěr. Teoretická část popisuje o finanční analýze a je doplněna o charakteristiky vybraných ukazatelů rentability, likvidity, zadluženosti, aktivity a bankrotních modelů. V praktické části je stručně představena analyzovaná firma a následně aplikovány poznatky z teoretické části při výpočtech hodnot ukazatelů a jejich interpretaci. Ukončena je závěrem a shrnutím poznatků.The aim of this bachelor thesis is to analyse and evaluate financial health of manufacturing company Epiag lofida -- Porcelán CZ s.r.o. in a period of years 2006 -- 2011. Thesis is devided into three parts: theoretical, practical and conclusion. In theoretical part, there is described methodology of calculations used in analysis - horizontal and vertical analysis of financial statements, indicators of profitability, liquidity, leverage, activity, bankrupt and financial standing models. The practical part consists of the application which is analyzed in the theoretical part of the thesis from different points of view. In conclusion of this thesis I evaluate results found in the practical part

The solid-phase partitioning of arsenic in unconsolidated sediments of the Mekong Delta, Vietnam and its modes of release under various conditions

Arsenic (As) contamination of the groundwater in the Mekong Delta is a serious problem affecting millions of people who rely on this important resource for drinking and agriculture. In this study, borehole cores up to a depth of 40 m were collected in the Vietnamese-side of the delta, and the solid-phase partitioning of As with depth was investigated to understand the factors and processes controlling the release of this toxic element under oxic, acidic and reducing conditions. The results showed that in most of the sediments, substantial amounts of As are partitioned with exchangeable phases that are easily released into solution. Two borehole cores obtained between the Hau and Tien Rivers also had significantly high As partitioned with organic/sulfide phases and one of these cores had abundant As-bearing pyrite in 1-m thick peat layers. Leaching experiments in deionized (DI) water coupled with principal component analysis suggest that As release was controlled by sorption-desorption reactions with clays/phyllosilicates (i.e., kaolinite, muscovite and clinochlore), proton-promoted dissolution of iron-oxyhydroxides, and oxidation of pyrite/organic matter. The mobility of As was further promoted under acidic conditions in the presence of chloride (Cl-), which suggests that seasonal drying/flooding episodes generating acid sulfate soils, as well as salt water intrusion due to excessive groundwater abstraction may exacerbate this problem in the future

Geological and geochemical characterizations of sediments in six borehole cores from the arsenic-contaminated aquifer of the Mekong Delta, Vietnam

The Mekong Delta, situated between Cambodia and Vietnam, is one of the most productive aquifer systems in the region. In recent years, however, several studies have shown that groundwater in several areas of the delta is highly contaminated with arsenic (As). Although more than 80% of the total area of the Mekong Delta is situated in Vietnam, most of the studies have been conducted on the Cambodian-side of the delta. In this study, borehole core samples were collected around the Tien and Hau Rivers, the two main branches of the Mekong River as it enters Vietnam. We present a raw data collection of the chemical and mineralogical composition of distinct lithological features from six borehole core samples drilled up to a depth of 40 m. The data also include the pH, Eh, EC, As, Si, Al, DOC, dissolved heavy metals (Fe and Mn) and major coexisting ions of leachates obtained by leaching the 34 selected sediment samples in deionized water. The information provided in this paper would be useful as a baseline for reactive transport or geochemical modeling to understand and predict As migration in naturally contaminated aquifers under various conditions. For more insights, the reader is referred to our paper entitled "The solid-phase partitioning of arsenic in unconsolidated sediments of the Mekong Delta, Vietnam and its modes of release under various conditions" Huyen et al., 2019

Anti-Aging Effects of a Serum Based on Coconut Oil Combined with Deer Antler Stem Cell Extract on a Mouse Model of Skin Aging

Anti-aging is one of the top goals in the field of health care and aesthetics. Anti-aging cosmetics derived from nature are oriented to long-term development, bringing safety to users and being environmentally friendly. The aim of this study was to develop an anti-aging cosmetic formulation process based on coconut oil in combination with deer antler stem cell extract. The results show that the presence of deer antler stem cell extract added to the foundation made the serum product highly stable and helped improve skin aging significantly after 2 weeks of use. The skin site where the serum product was applied showed a smooth and elastic skin surface, with very few fine lines and shallow wrinkles. Serum reduced the number of wrinkles (48.09% compared to commercial serum (ME) and 60.31% compared to positive control (PC)), reduced skin recovery time (39.31% compared to ME and 67.1% of PC) after two weeks of use. After 2 weeks of use, collagen density increased 10.18% compared to ME and 63.76% compared to control. Epidermal thickness increased by 106.1% compared to PC and 121.7% compared to ME